Herein we detail how next generation proteomics tools are solving limitations of traditional tools (IHC, ELISA, Mass Spectrometry, Flow Cytometry) and are adding functionality.
After years of relatively stagnant innovation in traditional proteomics tools, there are a myriad of new solutions that could lead to material advancements in the field. We estimate that the market opportunity across all classes of proteomics tools (traditional and emerging) could approximate if not exceed $50B.